Viewing Study NCT02096692


Ignite Creation Date: 2025-12-24 @ 3:36 PM
Ignite Modification Date: 2026-01-29 @ 3:59 PM
Study NCT ID: NCT02096692
Status: COMPLETED
Last Update Posted: 2016-02-29
First Post: 2014-03-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: ProMRI Study of the Iforia ICD System (Phase C)
Sponsor: Biotronik, Inc.
Organization:

Study Overview

Official Title: ProMRI Study of the Iforia ICD System (Phase C)
Status: COMPLETED
Status Verified Date: 2016-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of the ProMRI Study is to demonstrate the clinical safety of the ProMRI ICD System when used under specific MRI conditions.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: